- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:39 | BIBBINSTRUMENTS AB: BiBB Receives U.S. Patent Notice of Allowance for EndoDrill[] | 2 | Cision News | ||
| BIBBINSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 02.05. | BIBBINSTRUMENTS AB: BiBB and TaeWoong Medical USA Sign Letter of Intent for U.S. Commercialization of EndoDrillGI | 1 | Cision News | ||
| 07.04. | BIBBINSTRUMENTS AB: BiBB Receives Notice of Allowance for Additional EndoDrill Patent in China | 1 | Cision News | ||
| 26.03. | BIBBINSTRUMENTS AB: BibbInstruments' founder on clinical evaluations of EndoDrill GI | 1 | Cision News | ||
| 25.03. | BIBBINSTRUMENTS AB: EndoDrill GI - Effective and Safe According to New Results | 1 | Cision News | ||
| 18.03. | BIBBINSTRUMENTS AB: Successful Live Broadcasted Patient Case with EndoDrill GI in Porto, Portugal | 3 | Cision News | ||
| 05.03. | BIBBINSTRUMENTS AB: BiBBInstruments' CEO to "Agreements with distribution partners will be key to commercial success" | 2 | Cision News | ||
| 21.02. | BIBBINSTRUMENTS AB: First liver cases with EndoDrill GI performed in the USA | 1 | Cision News | ||
| 12.02. | BIBBINSTRUMENTS AB: BiBB participated in clinical cases with EndoDrill GI in Germany for the indication EUS-guided liver biopsy | 2 | Cision News | ||
| 03.02. | Spotlight Stock Market: Market Notice 29/25 Information regarding BiBBInstruments AB's subscription option | 2 | Cision News | ||
| 28.01. | BIBBINSTRUMENTS AB: BiBBInstruments CEO: "First order sends positive signals" | 1 | Cision News | ||
| 24.01. | BIBBINSTRUMENTS AB: BiBB receives first order for EndoDrill GI from a university hospital in the US | 1 | Cision News | ||
| 22.01. | BIBBINSTRUMENTS AB: BiBBInstruments announces final outcome of rights issue | 1 | Cision News | ||
| 21.01. | BIBBINSTRUMENTS AB: BiBBInstruments announces preliminary outcome of rights issue | 1 | Cision News | ||
| 27.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.12.2024 | 355 | Xetra Newsboard | Das Instrument 3330 DE000A3MQRK6 ROSTRA AGC INH O.N. EQUITY wird ex Kapitalmassnahme gehandelt am 27.12.2024 The instrument 3330 DE000A3MQRK6 ROSTRA AGC INH O.N. EQUITY is traded ex capital adjustment... ► Artikel lesen | |
| 19.12.24 | Spotlight Stock Market: Market Notice 271/24 - Information regarding the rights issue from BibbInstruments AB | 4 | Cision News | ||
| 25.11.24 | BIBBINSTRUMENTS AB: Clinical evaluation at Karolinska University Hospital is progressing | 2 | Cision News | ||
| 19.11.24 | BIBBINSTRUMENTS AB: BiBBInstrument' founder on the Sahlgrenska evaluation | 2 | Cision News |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 255,05 | -7,52 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| FRESENIUS | 42,390 | +1,48 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,500 | +0,73 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 0,671 | 0,00 % | Incannex Healthcare Inc. - 10-Q, Quarterly Report | ||
| FRESENIUS MEDICAL CARE | 50,94 | +1,88 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| BRIGHTSPRING HEALTH SERVICES | 23,480 | 0,00 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
| ALIGNMENT HEALTHCARE | 14,910 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| NUTEX HEALTH | 158,61 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| HIMS & HERS HEALTH | 53,10 | -3,03 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| GENEDX | 59,51 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| PROCEPT BIOROBOTICS | 54,75 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 61,40 | -0,81 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| BASEL MEDICAL GROUP | 1,640 | 0,00 % | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 5,820 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook | First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared... ► Artikel lesen | |
| PROGYNY | 21,860 | 0,00 % | Progyny erweitert Medizinischen Beirat um zwei renommierte Ärztinnen |
Das Unternehmen BIBBINSTRUMENTS AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,237 Euro und damit -1,25 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIBBINSTRUMENTS AB finden Sie auf Wallstreet Online.